195 related articles for article (PubMed ID: 18056261)
1. Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin.
Emami N; Diamandis EP
J Biol Chem; 2008 Feb; 283(6):3031-3041. PubMed ID: 18056261
[TBL] [Abstract][Full Text] [Related]
2. Major role of human KLK14 in seminal clot liquefaction.
Emami N; Deperthes D; Malm J; Diamandis EP
J Biol Chem; 2008 Jul; 283(28):19561-9. PubMed ID: 18482984
[TBL] [Abstract][Full Text] [Related]
3. Potential role of multiple members of the kallikrein-related peptidase family of serine proteases in activating latent TGF beta 1 in semen.
Emami N; Diamandis EP
Biol Chem; 2010 Jan; 391(1):85-95. PubMed ID: 19919178
[TBL] [Abstract][Full Text] [Related]
4. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
Yoon H; Blaber SI; Evans DM; Trim J; Juliano MA; Scarisbrick IA; Blaber M
Protein Sci; 2008 Nov; 17(11):1998-2007. PubMed ID: 18697857
[TBL] [Abstract][Full Text] [Related]
5. Activation profiles and regulatory cascades of the human kallikrein-related peptidases.
Yoon H; Laxmikanthan G; Lee J; Blaber SI; Rodriguez A; Kogot JM; Scarisbrick IA; Blaber M
J Biol Chem; 2007 Nov; 282(44):31852-64. PubMed ID: 17823117
[TBL] [Abstract][Full Text] [Related]
6. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
Borgoño CA; Michael IP; Komatsu N; Jayakumar A; Kapadia R; Clayman GL; Sotiropoulou G; Diamandis EP
J Biol Chem; 2007 Feb; 282(6):3640-52. PubMed ID: 17158887
[TBL] [Abstract][Full Text] [Related]
7. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.
Pampalakis G; Sotiropoulou G
Biochim Biophys Acta; 2007 Sep; 1776(1):22-31. PubMed ID: 17629406
[TBL] [Abstract][Full Text] [Related]
8. Variants in KLK11, affecting signal peptide cleavage of kallikrein-related peptidase 11, cause an autosomal-dominant cornification disorder.
Gong Z; Dai S; Jiang X; Lee M; Zhu X; Wang H; Lin Z
Br J Dermatol; 2023 Jan; 188(1):100-111. PubMed ID: 36689511
[TBL] [Abstract][Full Text] [Related]
9. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.
Yoon H; Blaber SI; Li W; Scarisbrick IA; Blaber M
Biol Chem; 2013 Jan; 394(1):137-47. PubMed ID: 23241590
[TBL] [Abstract][Full Text] [Related]
10. Interdependence of kallikrein-related peptidases in proteolytic networks.
Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V
Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517
[TBL] [Abstract][Full Text] [Related]
11. Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility.
Emami N; Scorilas A; Soosaipillai A; Earle T; Mullen B; Diamandis EP
Biol Chem; 2009 Sep; 390(9):921-9. PubMed ID: 19558318
[TBL] [Abstract][Full Text] [Related]
12. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.
Komatsu N; Saijoh K; Kuk C; Liu AC; Khan S; Shirasaki F; Takehara K; Diamandis EP
Exp Dermatol; 2007 Jun; 16(6):513-9. PubMed ID: 17518992
[TBL] [Abstract][Full Text] [Related]
13. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies.
Yousef GM; Magklara A; Chang A; Jung K; Katsaros D; Diamandis EP
Cancer Res; 2001 Apr; 61(8):3425-31. PubMed ID: 11309303
[TBL] [Abstract][Full Text] [Related]
14. Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity.
Skala W; Utzschneider DT; Magdolen V; Debela M; Guo S; Craik CS; Brandstetter H; Goettig P
J Biol Chem; 2014 Dec; 289(49):34267-83. PubMed ID: 25326387
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
[TBL] [Abstract][Full Text] [Related]
16. Activation and activity of glycosylated KLKs 3, 4 and 11.
Guo S; Briza P; Magdolen V; Brandstetter H; Goettig P
Biol Chem; 2018 Sep; 399(9):1009-1022. PubMed ID: 29975661
[TBL] [Abstract][Full Text] [Related]
17. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options.
Fischer J; Meyer-Hoffert U
Thromb Haemost; 2013 Sep; 110(3):442-9. PubMed ID: 23446429
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
Avgeris M; Scorilas A
Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
[TBL] [Abstract][Full Text] [Related]
19. New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.
Emami N; Diamandis EP
Mol Oncol; 2007 Dec; 1(3):269-87. PubMed ID: 19383303
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitory activity for serine protease inhibitor Kazal type-3 (Spink3) on human recombinant kallikreins.
Assis DM; Zalazar L; Juliano MA; De Castro R; Cesari A
Protein Pept Lett; 2013 Oct; 20(10):1098-107. PubMed ID: 23590280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]